Apollo AyurVAID, JNTBGRI in MoU to advance R&D in ayurveda-based herbal drug development

IMT News Desk
IMT News Desk
· 2 min read

The MoU was formally exchanged during the KSCSTE R&D Summit 2025, held in the presence of Chief Minister of Kerala, Pinarayi Vijayan

Apollo AyurVAID signed a Memorandum of Understanding (MoU) with the Jawaharlal Nehru Tropical Botanic Garden and Research Institute (JNTBGRI), an autonomous R&D institution under the Kerala State Council for Science, Technology and Environment (KSCSTE), to foster collaborative research in herbal drug development and standardisation.

The MoU was formally exchanged during the KSCSTE R&D Summit 2025, held in the presence of Chief Minister of Kerala, Pinarayi Vijayan. The summit, hosted Thiruvananthapuram, focussed on Translating R&D Innovations into Scalable Solutions, bringing together policymakers, researchers, industry leaders, and innovators from across the state and country.

Through this collaboration, Apollo AyurVAID and JNTBGRI will undertake joint R&D initiatives that span in silico drug design, raw herb authentication, phytochemical and pharmacological standardisation. The two institutions shall co-create frameworks for translational research that link discovery science with product development and therapeutic practice. The partnership also includes mutual support in applying for funding proposals, knowledge exchange, and scientific dissemination through lectures and seminars.

Rajiv Vasudevan, Founder, MD & CEO, Apollo AyurVAID, said, “By integrating JNTBGRI’s deep scientific expertise with Apollo AyurVAID’s two decades of precision Ayurveda experience, we are laying a stronger foundation for enhanced safety and efficacy of Ayurveda classical, proprietary and OTC products. Raw herb authentication, standardisation and product development that meet contemporary clinical and regulatory standards is envisaged under the partnership.”

Dr V Arunachalam, Director, KSCSTE-JNTBGRI, added, “This MoU reflects our vision to share scientific expertise in herbal drug research with credible partners across the healthcare ecosystem. In collaboration with Apollo AyurVAID, we aim to foster the sustainable use of biodiversity in developing Ayurvedic healthcare solutions by combining cutting-edge science, such as in silico approaches, pharmacology, traditional Ayurvedic practices, and animal model testing with time-honoured wisdom.”

Read Next

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability
News
May 18, 2026

Annora Pharma Expands Collaboration with AI-Native Traceability Platform AltiusHub to Strengthen Global Drug Traceability

Annora Pharma, the formulations subsidiary of Hetero Group, has expanded its collaboration with AltiusHub. The company is deploying AltiusHub’s AI-native serialization, track & trace and regulatory compliance platform across its export operations. The deployment is designed to improve serialization efficiency by up to 45%. It will also strengthen operational visibility across Annora Pharma’s global supply […]
Article by: IMT News Desk
WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation
News
May 18, 2026

WFNS Innovation & Technology Committee Announces Partnership with Time Medical International Ventures (India) Pvt Ltd for First-in-Class Medical Technology Innovation

The World Federation of Neurosurgical Societies (WFNS) Innovation & Technology Committee has announced collaboration with Time Medical International Ventures (India) Pvt. Ltd (Time Medical India)., a wholly owned subsidiary of Fischer Medical Ventures Limited, marking a significant milestone in advancing innovation in global neurosurgical care. This marks the first time the Committee has formally partnered […]
Article by: IMT News Desk
National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare
News
May 18, 2026

National AI Doctors Mission launches in New Delhi: How AI will change Indian healthcare

The National AI Doctors Mission (NAIDM) has been formally launched in New Delhi, marking a major step toward integrating artificial intelligence into everyday clinical practice across India’s public and private healthcare system. The initiative, led by Medical Dialogues in collaboration with the National Medical Forum, aims to make AI “useful and usable” for frontline doctors rather than […]
Article by: IMT News Desk
Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore
News
May 18, 2026

Gland Pharma rallies on upbeat Q4; profit soars 97% YoY to ₹367 crore

Gland Pharma shares extended gains in the capital markets after the company posted a standout Q4 performance, with consolidated net profit jumping 97% year‑on‑year to ₹367 crore, riding on a sharp improvement in operating leverage and a strong base‑business showing in the US. Revenue for the quarter rose 22% YoY to ₹1,743 crore, while EBITDA surged 48% YoY […]
Article by: IMT News Desk